Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
The Cancer Journal From Scientific American
|
February 24, 2000
Rationale for intergroup trial E-3695 comparing concurrent biochemotherapy with cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma
L E Flaherty
Current Oncology Reports
|
December 21, 2000
Biochemotherapy for melanoma
P A Philip, L E Flaherty
Cancer Journal (Sudbury, Mass.)
|
July 6, 2000
Adjuvant high-dose interferon revisited
V K Sondak, L E Flaherty
Journal of the National Cancer Institute
|
August 15, 1990
Case report: development of Hodgkin's disease in patient receiving long-term administration of dacarbazine and interleukin-2 for metastatic melanoma
L E Flaherty, R Schwert, B G Redman
American Journal of Clinical Oncology
|
December 10, 1997
Comparison of patient characteristics and outcome between a single-institution phase II trial and a cooperative-group phase II trial with identical eligibility in metastatic melanoma
L E Flaherty, P Y Liu, J Unger, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients
G G Chabot, L E Flaherty, M Valdivieso, et al.
American Journal of Clinical Oncology
|
October 1, 1996
A phase II evaluation of oral tamoxifen and intermittent intravenous vinblastine in hormone-refractory adenocarcinoma of the prostate
K J Pienta, B G Redman, P S Esper, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1986
Infection of T4 lymphocytes by HTLV-III does not require expression of the OKT4 epitope
J A Hoxie, L E Flaherty, B S Haggarty, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
October 1, 1994
Phase II trial of recombinant interleukin-1 beta in patients with metastatic renal cell carcinoma
B G Redman, Y Abubakr, T Chou, et al.
American Journal of Clinical Oncology
|
February 1, 1997
Phase II chemoprevention trial of oral fenretinide in patients at risk for adenocarcinoma of the prostate
K J Pienta, P S Esper, F Zwas, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
The Cancer Journal From Scientific American
|
February 24, 2000
Rationale for intergroup trial E-3695 comparing concurrent biochemotherapy with cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma
L E Flaherty
Current Oncology Reports
|
December 21, 2000
Biochemotherapy for melanoma
P A Philip, L E Flaherty
Cancer Journal (Sudbury, Mass.)
|
July 6, 2000
Adjuvant high-dose interferon revisited
V K Sondak, L E Flaherty
Journal of the National Cancer Institute
|
August 15, 1990
Case report: development of Hodgkin's disease in patient receiving long-term administration of dacarbazine and interleukin-2 for metastatic melanoma
L E Flaherty, R Schwert, B G Redman
American Journal of Clinical Oncology
|
December 10, 1997
Comparison of patient characteristics and outcome between a single-institution phase II trial and a cooperative-group phase II trial with identical eligibility in metastatic melanoma
L E Flaherty, P Y Liu, J Unger, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients
G G Chabot, L E Flaherty, M Valdivieso, et al.
American Journal of Clinical Oncology
|
October 1, 1996
A phase II evaluation of oral tamoxifen and intermittent intravenous vinblastine in hormone-refractory adenocarcinoma of the prostate
K J Pienta, B G Redman, P S Esper, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1986
Infection of T4 lymphocytes by HTLV-III does not require expression of the OKT4 epitope
J A Hoxie, L E Flaherty, B S Haggarty, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
October 1, 1994
Phase II trial of recombinant interleukin-1 beta in patients with metastatic renal cell carcinoma
B G Redman, Y Abubakr, T Chou, et al.
American Journal of Clinical Oncology
|
February 1, 1997
Phase II chemoprevention trial of oral fenretinide in patients at risk for adenocarcinoma of the prostate
K J Pienta, P S Esper, F Zwas, et al.
Page
of 4